drug · protein
patient view →afamelanotide acetate
Marketedupdated 2mo agoby Clinuvel Pharmaceuticals Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Protein drug with a maximum clinical stage of Approval, with an approval for erythropoietic protoporphyria.
targets
Melanocyte-stimulating hormone receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that